texas oncology more breakthroughs. more victories

Share:

 
 

Dr Scott Paulson: Role of Somatostatin Analogs, Biomarkers in Treatment of GEP-NETs

Publication: American Journal of Managed Care

Dr. Scott Paulson, medical director for the Neuroendocrine Research and Treatment Center at Texas Oncology–Baylor Charles A. Sammons Cancer Center discusses how somatostatins have been the most game-changing drug in the treatment landscape of gastroenteropancreatic neuroendocrine tumors.

Read the full story at American Journal of Managed Care.

Related Physicians

Related Cancer Centers